Inscripta Inscripta Acquires Infinome Biosciences, Sestina Bio The acquisitions suggest that Inscripta has shifted its focus to biomanufacturing following dozens of layoffs across two site closures in December. Inscripta Lays Off Dozens, Closes Colorado Headquarters, San Diego Office The genome editing technology firm appears to be consolidating around its Pleasanton, California, office as it attempts to pivot its business. Aldevron Gets License From Inscripta to Manufacture, Sell CRISPR Nuclease The nuclease was released by Inscripta in 2017 free of charge to the research community and for single-digit royalties for commercial applications. Penn State Licenses Genome Editing Tech to Inscripta The new technology enables the simultaneous use of multiple guide RNAs and will be used with Inscripta's Onyx digital genome engineering platform. Inscripta Licenses MAD7 CRISPR Nuclease to Hunterian Medicine Hunterian, based in Cambridge, Massachusetts, said it plans to use MAD7 in its gene editing programs to develop human therapeutics. Apr 5, 2021 Inscripta Closes $150M Series E Financing Round Mar 30, 2021 Novel CRISPR-Cas12a Orthologs Expand Gene Editing Toolkit for Plants Premium Oct 30, 2020 People in the News: New Appointments at CareDx, Qiagen, Inscripta, and More Jan 22, 2020 M&A Deals in MDx/Omics Research Tools Space Up 13 Percent in 2019 Premium Jan 7, 2020 Genome Editors Begin Lining Up for Inscripta's Onyx Platform Premium Dec 10, 2019 Inscripta Raises $125M in Series D Financing Round Oct 10, 2019 Omics Tools Firms See Opportunities in Burgeoning Synthetic Biology Industry Premium Sep 25, 2019 IPO Window Wide Open for Dx, Genomics Companies Premium Jun 26, 2019 Inscripta Looks to Combine CRISPR, Single-Cell Genomics, Synthetic Biology in New Platform Premium Apr 4, 2019 Inscripta Expands Series C Financing Round to $105.5M Mar 7, 2019 CRISPR License Agreements Prohibit Misuse, but Enforcement is Challenging Premium Dec 19, 2018 Gene Editing Company Inscripta Expands Series C Funding to $85.5M Sep 5, 2018 Gene Editing Company Inscripta Acquires Solana Biosciences Aug 28, 2018 Horizon Discovery Begins Leveraging Vast Portfolio of Genome Editing Technology Premium Breaking News Imaging Mass Cytometry Discovers Tumor Microenvironment Features Predicting Lung Cancer Outcomes Metastatic Tumor Subtypes Found With Expression Profiling GenomeWeb Top 40 up 4 Percent in January, Following Broader Upswing LumiraDx Receives Notice From Nasdaq Over Missed Listing Requirement Sherlock Biosciences to Acquire Sense Biodetection The Scan Study Links Evolution of Longevity, Social Organization in Mammals With the help of comparative phylogenetics and transcriptomics, researchers in Nature Communications see ties between lifespan and social organization in mammals. Tumor Microenvironment Immune Score Provides Immunotherapy Response, Prognostic Insights Using multiple in situ analyses and RNA sequence data, researchers in eBioMedicine have developed a score associated with immunotherapy response or survival. CRISPR-Based Method for Finding Cancer-Associated Exosomal MicroRNAs in Blood A team from China presents in ACS Sensors a liposome-mediated membrane fusion strategy for detecting miRNAs carried in exosomes in the blood with a CRISPR-mediated reporter system. Drug Response Variants May Be Distinct in Somatic, Germline Samples Based on variants from across 21 drug response genes, researchers in The Pharmacogenomics Journal suspect that tumor-only DNA sequences may miss drug response clues found in the germline.